China’s Xiaomi sees shares soar to record highs as new electric vehicle draws strong response

The stock fell after a report that its Medicare billing practices were under investigations by the Justice Department.

Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

Ford is under pressure to perform following crosstown rival GM easily topping Wall Street’s third-quarter expectations and raising key 2024 guidance targets.